The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Roche (Inst); Spanish Society of Medical Oncology

CEA expression patterns determine response and resistance to the CEA-TCB bispecific immunotherapy antibody in colorectal cancer patient derived organoids.
 
Reyes Gonzalez Exposito
No Relationships to Disclose
 
Maria Semmianikova
No Relationships to Disclose
 
Beatrice Griffiths
No Relationships to Disclose
 
Khurum Hayat Khan
Consulting or Advisory Role - Bayer Health
 
Louise J Barber
No Relationships to Disclose
 
Andrew Woolston
No Relationships to Disclose
 
Georgia Spain
No Relationships to Disclose
 
Katharina von Loga
No Relationships to Disclose
 
Amanda Swain
No Relationships to Disclose
 
Janet Thomas
No Relationships to Disclose
 
Annette Bryant
No Relationships to Disclose
 
David Mansfield
No Relationships to Disclose
 
Sheela Rao
No Relationships to Disclose
 
David J. Watkins
No Relationships to Disclose
 
Ian Chau
Honoraria - Amgen; Gilead Sciences; Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly; MSD Oncology; Roche/Genentech; Sanofi
Research Funding - Janssen-Cilag (Inst); Lilly (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck Serono; MSD; Sanofi
 
Naureen Starling
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Nik Matthews
No Relationships to Disclose
 
Fredrik Wallberg
No Relationships to Disclose
 
David Cunningham
Research Funding - 4SC (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Sanofi (Inst)
 
Marco Gerlinger
No Relationships to Disclose